ACC.25前瞻丨近百項中國心血管研究成果，即將閃耀國際舞臺！

2025-05-03 07:21 醫脈通心血管

當地時間3月29日至31日，第74屆美國心臟病學會科學年會（ACC.25）即將在美國芝加哥盛大召開。
在本屆年會上，中國學者將攜百餘篇前沿研究成果閃耀ACC舞臺，涵蓋了冠心病、心力衰竭、心律失常、高血壓、血脂異常等關鍵領域的新藥物、新技術或新器械，彰顯了我國學者在心血管領域的深厚學術積澱與前瞻性思維；不僅為臨床醫生的診療工作提供了更具科學性和有效性的新方案，更以其創新性和引領性，為全球心血管醫學的蓬勃發展注入了強勁動力。
本文根據官網日程，整理了ACC.25年會即將釋出的中國研究，如有遺漏或錯誤，歡迎廣大讀者提醒及指正。
3月29日:
1020 – Cardiac Arrhythmias 01
[Board 12] PATTERNS OF POST-ABLATION RECURRENCE AND ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
心房顫動患者消融術後的復發模式與不良心血管事件結局
李思彤, 張景瑞, 蔣超, Liu He, 周寧, 桑才華, 龍德勇, 杜欣, 董建增, 馬長生，首都醫科大學附屬北京安貞醫院
1021 – Cardiovascular Disease Prevention 01

[Board 21] EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR DISEASES (EXACOS-CV): ONE IN THREE COPD PATIENTS EXPERIENCED CARDIOPULMONARY EVENTS DURING FOLLOW-UP

EXACOS-CV試驗：三分之一的慢性阻塞性肺部疾病患者在隨訪時發生了心肺事件

Iok Fai Cheang, Wenhao Li, Zhike Liu, Meng Zhang, Yan Chen, Dongni Hou, Shaosen Zhang, Claudia Cabrera, Siyan Zhan, Feng Sun, Yuanlin Song, 李新立, Laurence Somerville，南京醫科大學第一附屬醫院
[Board 28] ASSOCIATIONS BETWEEN SEX, PREHOSPITAL DELAY, AND UNFAVORABLE IN-HOSPITAL OUTCOMES AMONG PATIENTS WITH ACUTE CORONARY SYNDROMES: FINDINGS FROM THE CHINESE CARDIOVASCULAR ASSOCIATION (CCA) DATABASE-CHEST PAIN CENTERREGISTRY
來自中國心血管協會（CCA）胸痛中心註冊資料庫的研究結果：急性冠脈綜合徵患者的性別、院前延誤與不良住院結局的關係
Tongtong Zang,  盧珍珍, 黃麗紅, 李申、葛均波, 復旦大學附屬中山醫院
[Board 33] TAFOLECIMAB IN CHINESE PATIENTS WITH DIABETES MELLITUS: A POOLED ANALYSIS OF EFFICACY AND SAFETY DATA FROM PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIALS
在中國糖尿病患者中使用Tafolecimab：來自3期隨機、安慰劑對照試驗的有效性和安全性資料的彙總分析
Litong Qi, 申華, Meng Chai, Beijian Chen, Yongming He, Xiaoxia Shi, Qiufang Lian, Shuiping Zhao, Yanling Qu, Lei Qian, Jianwei Zhang, Haoyu Li, 周玉傑, 霍勇, CREDIT-1, 2 and 4 investigators，首都醫科大學附屬北京安貞醫院，北京大學第一醫院
[Board 35] EFFECT OF APROCITENTAN ON BLOOD PRESSURE AND ALBUMINURIA IN PATIENTS WITH RESISTANT HYPERTENSION TREATED WITH SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS
(SGLT2I) Aprocitentan對進行SGLT2I治療的頑固性高血壓患者血壓和蛋白尿的影響
王繼光, John M. Flack, Krzysztof Narkiewicz, Martine Clozel, Peter Cornelisse, Roland Dreier, Mouna Sassi-Sayadi, Michael A. Weber, Markus Peter Schlaich，上海交通大學醫學院附屬瑞金醫院
Presentation | 1029 – Heart Failure and Cardiomyopathies 01
[Board 181] MULTI-FREQUENCY PHASE ANGLE AND SURVIVAL IN CHRONIC HEART FAILURE PATIENTS: A PROSPECTIVE, OBSERVATIONAL STUDY
一項前瞻性觀察性研究的結果：多頻相位角與慢性心力衰竭患者生存率的關係
Bryan Richard Sasmita, 謝林峰, 黃畢, 羅素新, 重慶醫科大學附屬第一醫院
Presentation | 1022 – Featured Fields 01
[Board 58] TOTAL BODY WATER TO LEAN BODY MASS RATIO PREDICTS MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE: A PROSPECTIVE, OBSERVATIONAL STUDY
一項前瞻性觀察性研究：在慢性心力衰竭患者，中總體液量與去脂體重的比值可預測死亡率
謝林峰, Jing Chen, 黃畢, Bryan Richard Sasmita, 羅素新, 重慶醫科大學附屬第一醫院
Presentation | 1274 – Valvular Diseases 01
[Board 128] FEMALE REPRODUCTIVE FACTORS AND RISK OF DEGENERATIVE VALVULAR HEART DISEASE
女性生殖因素與退行性心臟瓣膜病的風險
Xinli Guo, Changpeng Song，黃曉紅，中國醫學科學院阜外醫院
Presentation | 902 – Genetics and Genomics to Optimize Cardiovascular Health
ASSOCIATION OF PCSK9 GENE POLYMORPHISMS WITH ISCHEMIC EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE: A LONG-TERM PROSPECTIVE COHORT STUDY
一項長期前瞻性佇列研究結果：PCSK9基因多型性與冠狀動脈疾病患者缺血性事件之間的聯絡
Kailun Yan, Jiawen Li, Kexin Zhang, Menglu Liu, Jianxin Li, 魯向鋒, Jinqing Yuan, 趙雪燕，中國醫學科學院阜外醫院，中國醫學科學院北京協和醫學院
Presentation | 1047 – Coronary, Peripheral and Structural Interventions 02
[Board 106] SGLT2 INHIBITORS DELAY PROGRESSION OF CAROTID PLAQUE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A RETROSPECTIVE COHORT STUDY
一項回顧性佇列研究：SGLT2抑制劑可延緩2型糖尿病患者頸動脈斑塊的進展
Qiao-Qing Zhong, Paul Ambarus, Yuhan Yang, Yifan Bu, Adil Al-Karim Manji, Usman Ahmed, Feroze Mahmood, Robina Matyal，長沙市中心醫院，貝斯以色列女執事醫療中心
[Board 112] SAFETY AND EFFICACY OF IVABRADINE IN THE TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A REAL-WORLD PROPENSITY SCORE MATCHING STUDY
一項真實世界傾向性評分匹配研究：伊伐佈雷定治療急性心肌梗死（AMI）的安全性和有效性
顧天舒，Yukun Zhang, Sutao Hu, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 1049 – Heart Failure and Cardiomyopathies 02
[Board 129] PRESSURE OVERLOAD INDUCES MYOCARDIAL INSULIN RESISTANCE VIA INCREASING THE AT1R-ERK-TRIM72 PATHWAY-MEDIATED DEGRADATION OF INSULIN RECEPTOR
壓力超負荷透過增加AT1R-ERK-TRIM72通路介導的胰島素受體降解誘導心肌細胞胰島素抵抗
Qingqing Zhao, 舒鴻洋, 李思彤, 桑才華, 周寧, 杜欣, 馬長生, 首都醫科大學附屬北京安貞醫院
[Board 132] MAF1 AMELIORATES CARDIAC FIBROSIS BY REGULATING SFRP2 VIA INTERCELLULAR COMMUNICATION
MAF1透過細胞間通訊調控SFRP2，以改善心肌纖維化
Jiayong li, 薛睿聰，黃沛森，劉晨，中山大學附屬第一醫院
Presentation | 1045 – Ischemic Heart Diseases 02
[Board 73] THE VALUE OF PLASMA IMMUNOPROTEASOME FOR PREDICTING CORONARY COLLATERAL CIRCULATION IN ST-ELEVATION MYOCARDIAL INFARCTION
血漿免疫蛋白酶體在預測ST段抬高型心肌梗死（STEMI）冠狀動脈側支迴圈中的價值
Zhao Ma, Meichen Sun, JANG BO EUN, Yifei Nie, Chenchen Tu, XIN ZHAO, Huihua Li, dongfeng zhang, Xiantao Song, Hongjia Zhang，首都醫科大學附屬北京安貞醫院
Presentation | 1048 – Vascular Diseases 02
[Board 116] A PHASE 1, SINGLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SRSD107 IN HEALTHY ADULT SUBJECTS
SRSD107的1期單次遞增劑量試驗：在健康成年受試者中，評估SRSD107的安全性、耐受性、藥代動力學和藥效學特性
李姝雅，Patrick Yue, 王維聰，Emma Qu, jie pan, qunsheng ji, 北京天壇醫院，靖因藥業(Sirius Therapeutics)
Presentation | 1066 – Ischemic Heart Diseases 03
[Board 77] PROGNOSTIC VALUE OF OBSTRUCTIVE SLEEP APNOEA IN PATIENTS WITH ACUTE CORONARY SYNDROME IN RELATION TO LIPOPROTEIN(A) LEVEL
在急性冠狀動脈綜合徵（ACS）患者中，阻塞性睡眠呼吸暫停的預後價值與脂蛋白(a)水平有何關係
Yuyao Qiu, Wen Hao, Zekun Zhang, Bin Wang, 郭謙, Que Bin, Wei Gong, 鄭文，王曉，聶紹平，首都醫科大學附屬北京安貞醫院
Presentation | 1063 – Featured Fields 03
[Board 62] INTERVENTION THERAPY VERSUS CONSERVATIVE THERAPY OF NON-ST ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH DEMENTIA : A MULTI-CENTER REAL-WORLD STUDY
一項多中心真實世界研究：在合併痴呆的非ST段抬高型心肌梗死（NSTEMI）患者中對比介入治療與保守治療的療效
Rongxin Guo, Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 928 – ACC Complex Clinical Cases: Pulmonary Vascular Disease (Session 1)
A CASE OF CBLC TYPE METHYLMALONIC ACIDURIA WITH PULMONARY HYPERTENSION AS THE FIRST MANIFESTATION
1例以肺動脈高壓為首發症狀的CBLC型甲基丙二酸尿症患者
Anqi Duan, Zhihua Huang, Zhihui Zhao, Qing Zhao, 柳志紅，Qin Luo, 中國醫學科學院阜外醫院
Presentation | 1083 – Cardiovascular Disease Prevention 04
[Board 20] ASSOCIATION OF FRAILTY AND HIGH SENSITIVITY C-REACTIVE PROTEIN WITH CARDIOVASCULAR DISEASE IN MIDDLE-AGED AND OLDER ADULTS: A NATIONWIDE PROSPECTIVE COHORT STUDY
一項全國性、前瞻性佇列研究：中老年人衰弱和高敏C反應蛋白與心血管疾病的關係
Menglu Liu, Jiawen Li, Kailun Yan, Kexin Zhang, 袁晉青，趙雪燕，中國醫學科學院阜外醫院
[Board 22] PREDICTIVE VALUE OF MULTIPLE INSULIN RESISTANCE BIOMARKERS FOR CARDIOVASCULAR EVENTS IN ACS PATIENTS WITH DIFFERENT GLUCOSE METABOLISM STATUSES
在不同糖代謝狀態下，多種胰島素抵抗生物標誌物對ACS患者心血管事件的預測價值
Menglu Liu, Jiawen Li, Kailun Yan, Kexin Zhang, 袁晉青，趙雪燕，中國醫學科學院阜外醫院
Presentation | 1083 – Cardiovascular Disease Prevention 04
[Board 111] INVASIVE OR CONSERVATIVE MANAGEMENT OF CHRONIC CORONARY DISEASE PATIENTS WITH A HISTORY OF CORONARY HEART DISEASE: INSIGHTS FROM THE ISCHEMIA TRIALS
來自ISCHEMIA試驗的見解：在冠心病病史的慢性冠狀動脈疾病患者中，對比侵入性治療與保守治療的療效
Yun Zhou, Wei Gong, 聶紹平，首都醫科大學附屬北京安貞醫院
Presentation | 1091 – Heart Failure and Cardiomyopathies 04
[Board 178] EXPLORING RISK FACTORS OF CARDIOVASCULAR EVENTS IN PATIENTS WITH DIFFERENT TYPES OF SYNDROMIC AND METABOLIC CARDIOMYOPATHY
不同型別綜合徵和代謝性心肌病患者心血管事件危險因素的探討
Qing Yang, 梁巖，趙世華，中國醫學科學院阜外醫院
[Board 179] CHARACTERISTICS AND PREDICTORS OF CARDIAC OUTCOMES IN PATIENTS WITH SYNDROMIC AND METABOLIC CARDIOMYOPATHIES
綜合徵和代謝性心肌病患者心臟結局的特徵和預測因素
Qing Yang, 梁巖，中國醫學科學院阜外醫院
Presentation | 1277 – Valvular Diseases 04
[Board 122] ASSOCIATIONS BETWEEN SWEETENED BEVERAGES CONSUMPTION, DEGENERATIVE VALVULAR HEART DISEASE, AND RELATED EVENTS: A PROSPECTIVE STUDY FROM UK BIOBANK
一項來自UK BIOBANK的前瞻性研究：飲用含糖飲料與退行性瓣膜病及相關事件的相關性
朱兆偉，Wen Gong，成蔚，周勝華，中南大學湘雅二醫院 
Presentation | 1104 – Cardiovascular Disease Prevention 05
[Board 19] BODY ROUNDNESS INDEX AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASES INCIDENCE AMONG US ADULTS
在美國成年人中，身體圓度指數（BRI）與動脈粥樣硬化性心血管疾病（ASCVD）發病率之間的關係
Jiayi Yi, Hai Gao, Chao Qu, Xiang Li，首都醫科大學附屬北京安貞醫院
[Board 25] OLIVE OIL CONSUMPTION WITH RISK OF ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE COHORTS
一項前瞻性佇列研究的系統評價與薈萃分析：橄欖油攝入與全因死亡率及特定病因死亡風險之間的關係
Yu Feng, Xiangjun Wang, Cheng Wei, ziyue li, Bohao Tan, Kang Wang, Yue Sheng, Danyan Xu, 周勝華，Zhangling Chen，中南大學湘雅二醫院 
[Board 30] ASSOCIATIONS OF A HEALTHY BEVERAGE SCORE WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY AMONG U.S. ADULTS
在美國成年人中，健康飲品評分與全因死亡率和心血管疾病死亡率之間的關係
Yu Feng, Haoming Wang, Kang Wang, Bohao Tan, ziyue li, Qiming Liu, Xuping Li, 周勝華, Fan Ouyang, Zhangling Chen，中南大學湘雅二醫院
[Board 39] ASSOCIATIONS BETWEEN PLANT-BASED DIETS AND TOTAL MORTALITY AMONG PARTICIPANTS WITH CARDIOMETABOLIC DISEASES
在罹患心臟代謝疾病的患者中，植物性飲食與總死亡率之間的關係
Bohao Tan, Pengfei Chen, Kang Wang, Xiangjun Wang, Cheng Wei, Fei Luo, ziyue li, Yu Feng, Qiming Liu, Xinqun Hu, 周勝華，Zhangling Chen, 中南大學湘雅二醫院
Presentation | 1108 – Ischemic Heart Diseases 05
[Board 76] PROGNOSTIC IMPLICATIONS OF OBSTRUCTIVE SLEEP APNEA IN ACUTE CORONARY SYNDROME BY METABOLIC SYNDROME STATUS
根據代謝綜合徵狀態分析阻塞性睡眠呼吸暫停在ACS患者中的預後意義
Xiaochen Liu, Yuyao Qiu, 郭謙, Feiyu Zhang, cheng yating, mingrui zhang, Wen Hao, 鄭文, 王曉, 聶紹平，首都醫科大學附屬北京安貞醫院
[Board 77] CORONARY ANGIOGRAPHY VERSUS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR CORONARY ARTERY EVALUATION IN PATIENTS WITH HEART FAILURE
在心衰患者中，對比冠狀動脈造影和冠狀動脈計算機斷層掃描血管造影在冠狀動脈評估中的價值
Zhu Li, 黃畢，羅素新，重慶醫科大學附屬第一醫院
Presentation | 938 – Critical Care Cardiology Perspectives: Shocking Headlines in Cardiogenic Shock
MACHINE LEARNING FOR PREDICTING THE PROGNOSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK
應用機器學習預測AMI合併心源性休克患者的預後
黃畢, Jing Chen, 謝林峰，羅素新，重慶醫科大學附屬第一醫院
Presentation | 1105 – Featured Fields 05
[Board 50] VARIATIONS IN TREATMENT PATHWAYS AND OUTCOMES RELATED TO INITIAL PRESENTATIONS IN TAKOTSUBO SYNDROME
與Takotsubo綜合徵初始表現相關的治療途徑和結果差異
Mingxiao Li, Shuwen Zheng, Liu He, 孫藝紅，首都醫科大學附屬北京安貞醫院
[Board 52] EFFECT OF XUEBIJING ON THE PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY SEVERE INFECTION – Yukun Zhang
血必淨對AMI合併嚴重感染患者預後的影響
Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 937 – Emerging Therapeutic Insights For Valvular Heart Disease Management
PREDICTION MODEL FOR SUPRA THRESHOLD CEREBRAL ISCHEMIC LESION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
經導管主動脈瓣置換術後超閾值腦缺血損傷的預測模型
Jiaqi Fan, Jun Chen, 劉先寶，王建安，浙江大學醫學院附屬第二醫院
Presentation | 902 – Genetics and Genomics to Optimize Cardiovascular Health
DECODING GENETIC INSIGHTS INTO CARDIOVASCULAR HEALTH: POLYGENIC RISK SCORE FROM LIFE’S ESSENTIAL 8 AND DISCOVERY OF A NOVEL GLYCEMIC GENE IN THE TAIWAN BIOBANK
心血管健康的遺傳見解：生命八要素的多基因風險評分和臺灣生物庫新血糖基因的發現
Po-Juii Lai、Hsu Xin-Yin Hsu、Ming-Chieh Tsai、Chih-Jun Lai、Xien-Yu Fan、Kuo-Longg Chien，臺灣大學
Presentation | 1107 – Multimodal Imaging 05
[Board 72] VALIDATION OF A DEEP LEARNING-BASED ALGORITHM IN QUANTIFYING TRICUSPID VALVE REGURGITATION
基於深度學習的機器演算法在量化三尖瓣反流方面的驗證
Chenxu Zhao, Fei Yu, Zhubo Jiang, Feiqiong Huang, Scott D. Dougherty, Hoi Lee Bertha Ma, Alex Pui-Wai Lee, 香港威爾斯親王醫院
Presentation | 236 – Risky Business: Tackling Lipids in High-Risk Populations
Case Presentation: Hypertriglyceridemia and Primary Prevention – Ngai-Yin Chan
病例介紹：高甘油三酯血癥與一級預防
Ngai-Yin Chan，香港
3月30日:
Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials V (Session 107)
Comparison of Angiography-Derived Fractional Flow Reserve-Guided and Intravascular Ultrasound-Guided Percutaneous Coronary Intervention Strategies: The FLAVOUR II Trial
FLAVOUR II試驗：比較血管造影衍生的血流儲備分數指導與血管內超聲指導的經皮冠脈介入治療的療效
胡新央, 張金龍, Jun Jiang, Xiaoping Peng, Dongsheng Lu, Yibin Pan, Lijun Guo, Jilin Li, WENMING HE, Hao Zhou, Jun Pu, Jinyu Huang, Fan Jiang, Qiang Liu, Daqing Song, Liang Lu, Zhenfeng Cheng, Bin Yang, JIANLIANG MA, Peng Chen, Eun-Seok Shin, Shengxian Tu, Bon Kwon Koo, 王建安, FLAVOUR II Investigators, 浙江大學醫學院附屬第二醫院
Presentation | 311 – Pushing the Envelope on Permissive Cardiotoxicity: How Far Can We Go?
Are We Okay With Rechallenge in Cases of 5FU Induced Vasospasm?
在5FU誘導的血管痙攣病例中，我們可以接受再激發試驗嗎？
孫藝紅，首都醫科大學附屬北京安貞醫院
Presentation | 1123 – Cardiac Arrhythmias 06
[Board 1] CATHETER ABLATION FOR ATRIAL FIBRILLATION WITH NON-MODIFIABLE RECURRENCE RISK FACTORS: RESULTS FROM THE CABANA TRIAL
來自CABANA試驗的結果：具有不可改變復發風險因素的房顫導管消融治療的療效
Zhen Wang, Yanfang Wu, 蔣超，周寧，桑才華，杜欣，馬長生，首都醫科大學附屬北京安貞醫院
Presentation | 1130 – Coronary, Peripheral and Structural Interventions 06
[Board 100] PERCUTANEOUS CORONARY INTERVENTION VERSUS OPTIMAL-MEDICAL-THERAPYIN PATIENTS WITH BORDERLINE CORONARY LESIONSAT HIGH RISK FOR BLEEDING
對於存在高出血風險且患有臨界冠狀動脈病變的患者，經皮冠狀動脈介入治療（PCI）與最佳藥物治療的療效比較
Jiayu Wang, Yukun Zhang, Sutao Hu, 顧天舒, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
[Board 102] THE EFFECT OF PERCUTANEOUS CORONARY INTERVENTIONON PATIENTSWITH FRAILTY AND NON-ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION
PCI治療對合並虛弱的NSTEMI患者的影響
Sutao Hu, Yukun Zhang, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，劉彤，Jinhua Zhao, 陳康寅，天津醫科大學第二醫院
[Board 103] LONG-TERM CLINICAL OUTCOMES OFAPOLYMER-FREE SIROLIMUS-ELUTING STENT IN REAL-WORLD
在真實世界中，無聚合物西羅莫司洗脫支架的長期臨床結果
Sutao Hu, Yukun Zhang, 顧天舒, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林, Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
[Board 105] COMPARISON BETWEEN BUMA AND RESOLUTE CORONARY STENT SYSTEMON CLINICAL EFFICACY
BUMA和冠狀動脈支架臨床療效的比較
Mayi Zheng, Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
[Board 99] LONG-TERM PERFORMANCE OF THE SECOND GENERATION DRUG-ELUTING STENTS IN REAL-WORLD CLINICAL PRACTICE: THREE-YEAR CLINICAL OUTCOMES FROM A RETROSPECTIVE MULTICENTER DATASET
一項多中心、回顧性研究的3年臨床結果：第二代藥物洗脫支架在真實世界臨床實踐中的長期療效
Jiayi Ren, Yukun Zhang, Sutao Hu, 顧天舒, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 1128 – Ischemic Heart Diseases 06
[Board 80] THE RELATIONSHIP BETWEEN NEUTROPHIL- PERCENTAGE-TO- ALBUMIN RATIO (NPAR) AND LONG-TERM ADVERSE OUTCOMES IN PATIENTS WITH MYOCARDIAL INFARCTION AND NON-OBSTRUCTIVE CORONARY ARTERIES (MINOCA)
在非阻塞性冠狀動脈心肌梗死（MINOCA）患者中，中性粒細胞百分比/白蛋白比值（NPAR）與長期不良結局的關係
Yanwen Fang, Sizhuang Huang, Hao Zhang, Lingzhi Zhong, Mengyue Yu, 中國醫學科學院阜外醫院，中國醫學科學院北京協和醫學院
[Board 81] COMBINED RISK ESTIMATES OF METABOLIC RISK FACTORS AND CORONARY ANGIOGRAPHY-DERIVED INDEX OF MICROCIRCULATORY RESISTANCE IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION
在STEMI患者中，應用代謝危險因素和冠脈造影衍生的微迴圈阻力指數（Angio-IMR）進行綜合風險評估
郭謙，王曉，Yingying Guo, Yuyao Qiu, Que Bin, 龍德勇，聶紹平，首都醫科大學附屬北京安貞醫院
[Board 84] THE LONG-TERM PROGNOSTIC VALUE OF THE FRAMINGHAM RISK SCORING IN PATIENTS WITH MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERIES
FRAMINGHAM風險評分在MINOCA患者長期預後評估中的價值

Hao Zhang, Yanwen Fang, Sizhuang Huang, Lingzhi Zhong, Mengyue Yu, 中國醫學科學院阜外醫院，中國醫學科學院北京協和醫學院，北京大學人民醫院

[Board 85] RADIOMIC FEATURES FROM NON-CONTRAST CINE CARDIAC MRI PREDICT LONG-TERM ST-ELEVATION MYOCARDIAL INFARCTION OUTCOMES
探究非對比CINE心臟磁共振成像的放射學特徵，在預測STEMI長期預後中的價值
Wen Zheng, 郭謙, Yingying Guo, Hui Ai, Bin Que, 王曉, 聶紹平，首都醫科大學附屬北京安貞醫院
Presentation | 1125 – Featured Fields 06
[Board 42] OPPOSITE ASSOCIATIONS OF SERUM URIC ACID WITH ABDOMINAL AORTIC ANEURYSM IN DIABETIC VS. NON-DIABETIC POPULATION
在糖尿病和非糖尿病人群中，對比血清尿酸與腹主動脈瘤的相反關係
Ao Shi, Teng Zhang, Changzhi Liu, Ting Zhou, Shivon Sudesh, jing zhang, jianping liu, songyuan luo, Kaixiong Qing, Peng Yu，江西醫學院第二附屬醫院
Presentation | 1144 – Cardiovascular Disease Prevention 07
[Board 20] MONOCYTE-TO-APOLIPOPROTEIN A1 RATIO, A NOVEL BIOMARKER FOR PREDICTING DEATH AMONG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A LARGE-SCALE AND LONG-TERM FOLLOW-UP STUDY
一項大規模長期隨訪試驗：探究新型生物標誌物單核細胞與載脂蛋白A1比值在預測PCI患者死亡中的價值
Kailun Yan, Jiawen Li, Kexin Zhang, Menglu Liu, 袁晉青, 趙雪燕, 中國醫學科學院阜外醫院
[Board 33] 24 HOUR AMBULATORY BLOOD PRESSURE CONTROL IN CHINA: A NATIONWIDE DATABASE REPORT
全國資料庫報告：中國24小時動態血壓控制狀況
劉靖，北京大學人民醫院
Presentation | 1152 – Heart Failure and Cardiomyopathies 07
[Board 134] TYPE 2 DIABETES MELLITUS, PREDIABETES, AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY AFTER SEPTAL MYECTOMY
梗阻性肥厚型心肌病患者進行間隔肌切除術後的2型糖尿病、糖尿病前期和心血管結局
Tao Lu，王水雲，中國醫學科學院阜外醫院
Presentation | 1151 – Vascular Diseases 07
[Board 117] COMPARISON OF 3-YEAR CLINICAL OUTCOMES OF AMI PATIENTS: PROMUS PREMIER STENT VS BUMA STENT
在AMI患者中，植入PROMUS PREMIER支架或BUMA支架患者的3年臨床療效對比
Shan Cao, Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
[Board 118] PREOPERATIVE AND POSTOPERATIVE DIFFERENCES IN THE RADIAL ARTERY IN PATIENTS UNDERGOING FIRST VERSUS MULTIPLE TRANSRADIAL INTERVENTIONS
對比首次與多次經橈動脈介入治療患者，橈動脈的術前和術後差異
Hailong Si, Ximing Li, Yuna Wang, Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林, Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 965 – Hypertrophic Cardiomyopathy: Imaging, Therapeutic Options and Biomarkers
PROGNOSTIC VALUE OF ANGIOGRAPHY-DERIVED INDEX OF MICROVASCULAR RESISTANCE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
血管造影衍生的微迴圈阻力指數對肥厚型心肌病患者的預後價值
蔣峻，Yuxuan Zhang, Rui Ji, Shuxin Lei, Jingnan Pan, Zining Chen, Shitian Guo, Delong Chen, Abuduwufuer Yidilisi, Jiacheng Fang, Yiyue Zheng, Xinyi Zhang, Chi Liu, Jiniu Huang, Jianping Xiang, Xiaojie Xie, 王建安，浙江大學醫學院附屬第二醫院
Presentation | 1165 – Cardiovascular Disease Prevention 08
[Board 23] EFFECT OF IN-HOSPITAL INITIATION OF ALIROCUMAB ON CLINICAL OUTCOMES IN CHINESE ACUTE CORONARY SYNDROME PATIENTS: A DATABASE-BASED RETROSPECTIVE ANALYSIS
基於資料庫的回顧性分析：在中國ACS患者住院期間開始使用阿利西尤單抗對臨床結局的影響
Yani Yu, Dandan Li, Dongkai Shan, Xiaodan Tuo, Zongxing Li, 陳韻岱，中國人民解放軍總醫院
[Board 36] TRENDS IN RACIAL AND ETHNIC DISPARITIES IN ADVANCED CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME AMONG U.S. ADULTS: INSIGHTS FROM NHANES 2011-2020
來自NHANES 2011-2020的見解：在美國晚期心血管-腎臟-代謝（CKM）綜合徵成年患者中的種族差異
楊歡歡, Chenxi Huang, Mitsuaki Sawano, Jeph Herrin, Kamil Faridi, Zhihui Li, Erica Sarah Spatz, Harlan M. Krumholz, Yuan Lu ,耶魯大學紐黑文醫院，清華大學
Presentation | 1169 – Ischemic Heart Diseases 08
[Board 80] ONE-YEAR CLINICAL OUTCOMES OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING LONG-TERM REGULAR HEMODIALYSIS VERSUS PERITONEAL DIALYSIS: A RETROSPECTIVE COHORT STUDY
一項回顧性佇列研究：長期定期血液透析與腹膜透析患者AMI的1年臨床結局對比
Hao Zhang, Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 1167 – Pulmonary Vascular Disease 08
[Board 65] EFFECTS OF COMBINED RIOCIGUAT AND ENDOTHELIN RECEPTOR ANTAGONIST THERAPY IN CHINESE PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
在中國肺動脈高壓患者中，聯合應用利奧西呱和內皮素受體拮抗劑治療的療效
Anqi Duan, Zhihua Huang, Zhihui Zhao, Qing Zhao, XIN LI, Sicheng Zhang, Luyang Gao, Qin Luo, 柳志紅，中國醫學科學院阜外醫院
Presentation | 1166 – Featured Fields 08
[Board 56] AN INTERPRETABLE MACHINE LEARNING MODEL USING ROUTINE LAB TESTS TO PREDICT 1-YEAR CARDIAC DEATHIN AMI PATIENTS POST-PCI
探究基於常規實驗室測試的可解釋機器學習模型，用於預測AMI患者PCI治療後1年的心臟死亡
hongya liu, Yukun Zhang, Sutao Hu, 顧天舒, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林, Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 965 – Hypertrophic Cardiomyopathy: Imaging, Therapeutic Options and Biomarkers
PROTEOMIC PROFILING AND ITS ASSOCIATION WITH GENETIC MUTATIONS AND CLINICAL INDICATORS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
梗阻性肥厚型心肌病的蛋白質組學特徵及其與基因突變和臨床指標的關係
Xinli Guo, Changpeng Song，黃曉紅，中國醫學科學院阜外醫院
Presentation | 962 – Complex PCI
ASSOCIATION BETWEEN ROTATIONAL ATHERECTOMY SPEED AND PERIPROCEDURAL MYOCARDIAL INFARCTION: INSIGHTS FROM THE ROTA CHINA REGISTRY
來自ROTA中國註冊的觀點：旋磨速度與圍手術期心肌梗死的關係
Yuekun Zhang, 郭謙，鄭文，Wen Hao, 王曉，聶紹平，首都醫科大學附屬北京安貞醫院
Presentation | 964 – What's New in the World of Hypertrophic Cardiomyopathy
PROTEOMIC PROFILING PREDICTS GENE MUTATION IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
應用蛋白質組學特徵預測梗阻性肥厚型心肌病患者的基因突變
Xinli Guo, Changpeng Song，黃曉紅，中國醫學科學院阜外醫院
Presentation | 1186 – Cardiovascular Disease Prevention 09
[Board 31] SLEEP DURATION, DEPRESSION AND CARDIOVASCULAR DISEASE, A NATIONAL COHORT STUDY
一項全國性佇列研究：探究睡眠時長、抑鬱與心血管疾病的關係
Shandong Yu，首都醫科大學附屬北京友誼醫院
Presentation | 1190 – Ischemic Heart Diseases 09
[Board 73] SAFETY AND EFFICACY OF ACIPIMOX IN COMBINATION WITH STATINS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND ELEVATED TRIGLYCERIDE LEVELS
在甘油三酯水平升高的AMI患者中，探究阿昔莫司聯合他汀類藥物治療的安全性和有效性
顧天舒，Yukun Zhang, Sutao Hu, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao，劉彤，陳康寅，天津醫科大學第二醫院
[Board 74] COMPARISON OF THE SAFETY AND EFFICACY BETWEEN TICAGRELOR AND CLOPIDOGREL IN MYOCARDIAL INFARCTION PATIENTS WITH FRAILTY : A MULTI-CENTER OBSERVATIONAL STUDY
一項多中心觀察性研究：在衰弱的心梗患者中，對比替格瑞洛和氯吡格雷治療的安全性和有效性
Rongxin Guo, Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 981 – Insights Into Chronic Coronary Syndromes
PROGNOSTIC SIGNIFICANCE OF THE CORONARY MICROCIRCULATORY DYSFUNCTION IN DEFERRED INTERMEDIATE STENOTIC VESSELS
冠狀動脈微迴圈功能障礙在遲發性中度血管狹窄患者中的預後意義
蔣峻，Abuduwufuer Yidilisi, Delong Chen, Jinlong Zhang, Xinyang Hu, Yuxuan Zhang, Jiacheng Fang, Yiyue Zheng, Bon Kwon Koo, Jianping Xiang, 王建安，浙江大學醫學院附屬第二醫院
Presentation | 982 – Exciting Times For Cardiac Imaging: Relevant Clinical and Translational Science
PLAQUE INFLAMMATION INCREASES PLAQUE VULNERABILITY IN PATIENTS WITH CORONARY ARTERY DISEASE: A 3-VESSEL OPTICAL COHERENCE TOMOGRAPHY STUDY
一項三支血管光學相干斷層掃描試驗：在冠狀動脈疾病患者中，斑塊炎症增加斑塊易損性
Xiaochen Liu, Bin Wang, Yuyao Qiu, 郭謙，Yingying Guo, Yuekun Zhang, 王曉，聶紹平，首都醫科大學附屬北京安貞醫院
Presentation | 1206 – Cardiac Arrhythmias 10
[Board 9] LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION COMBINED WITH CRYOBALLOON ABLATION FOR VENTRICULAR TACHYCARDIA
在室性心動過速患者中，探究左心室輔助裝置聯合冷凍球囊消融的療效
Shuang Zhang, 李旭平，中南大學湘雅二醫院
Presentation | 1215 – Heart Failure and Cardiomyopathies 10
[Board 142] REAL-WORLD EVALUATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AFTER MYOCARDIAL INFARCTION
在真實世界中，評估血管緊張素轉換酶抑制劑在心梗合併射血分數保留的心衰患者中的療效
顧天舒，Yukun Zhang, Sutao Hu, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 1211 – Ischemic Heart Diseases 10
[Board 73] THE IMPACT OF QISHEN YIQI DRIPPING PILLS ON PROGNOSIS IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH FRAILTY
芪參益氣滴丸對衰弱AMI患者預後的影響
Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
[Board 85] SODIUM-DEPENDENT GLUCOSE TRANSPORTERS 2 INHIBITORS IMPROVE THE SHORT-TERM PROGNOSIS IN CHRONIC KIDNEY DISEASE PATIENTS WITH ACUTEMYOCARDIAL INFARCTION
SGLT-2抑制劑可改善合併AMI的慢性腎病患者的短期預後
Xue Zhang, Yukun Zhang, Sutao Hu, 顧天舒, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 1283 – Valvular Diseases 10
[Board 121] TRANSCATHETER TRICUSPID ANNULOPLASTY USING K-CLIP™ IN PATIENTS WITH RIGHT VENTRICULAR-PULMONARY ARTERIAL UNCOUPLING
K-CLIP™經導管三尖瓣環成形術治療右心室-肺動脈解偶聯患者的療效
Dawei Lin, 周達新，葛均波，復旦大學附屬中山醫院
Presentation | 1214 – Vascular Diseases 10
[Board 117] STUDY OF OPTIMIZED HEMOSTASIS AND REHABILITATION STRATEGIES FOR PREVENTION OF RADIAL ARTERY OCCLUSION AFTER RE-TRANSRADIAL INTERVENTION
經橈動脈介入術後預防橈動脈閉塞的最佳化止血與康復治療策略研究
Hailong Si, Ximing Li, Yuna Wang, Yukun Zhang, Sutao Hu,顧天舒, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林, Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
[Board 53] DETECTING ECHOCARDIOGRAPHIC PARAMETERS FROM ELECTROCARDIOGRAMS IN HEMODYNAMICALLY SIGNIFICANT AORTIC REGURGITATION USING DEEP LEARNING
利用深度學習從心電圖中檢測出具有血流動力學意義的主動脈瓣反流的超聲心動圖引數
Meng-Han Tsai, Kuang-Chien Chiang, Yi Ting Li, Li-Tan Yang，臺灣台大醫院
3月31日:
Clinical and Investigative Horizons I (Session 402)
Effect of Berberine Hydrochloride on Visceral and Liver Fat in Non-Diabetic Individuals With Visceral Adiposity
鹽酸小檗鹼對非糖尿病患者內臟型肥胖患者內臟脂肪和肝臟脂肪的影響
Lubi Lei, Bin Wang, yinchu Li, Haibo Zhang, Jing Li, on behalf of the BRAVO Collaborative Group, 中國醫學科學院阜外醫院
Clinical and Investigative Horizons II (Session 434)
Efficacy and Safety of SHR-1918, an Angiopoietin-like 3 Monoclonal Antibody, in Combination With Lipid-Lowering Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Multicenter, Randomized, Double Blind, Placebo-Controlled Phase 2 Trial
一項多中心、隨機、雙盲、安慰劑對照2期試驗：血管生成素樣蛋白3的單克隆抗體SHR-1918與降脂治療聯合應用對控制欠佳的高脂血症患者的療效和安全性
王建安, 謝小潔, Xiaoxia Shi, Yuming Zhang, Shuhong Su, Chengyan Jiang, Liu Miao, Junkui Wang, Daoquan Peng, Lingchun Lv, Xiaohong Chai, Suxin Luo, Yang Zheng, Shan Huang, Dan Zhu, Shangshang Liao, Meng Ren, Xiaohong Gao, Haibo Yang, Hao Zhou, Chao Lv, Min Zhu, Ying Zhu, 浙江大學醫學院附屬第二醫院
Homogeneous Effects of Intensive Blood Pressure Control in Patients With Various Frailty Status: A Post-hoc Analysis of the Esprit Trial
Esprit試驗事後分析：不同虛弱狀態患者強化降壓治療的同質效應
Shitian Li, Jiamin Liu, 張海波，李靜, 中國醫學科學院阜外醫院
Presentation | 1227 – Cardiovascular Disease Prevention 11
[Board 20] A REAL-WORLD EVALUATION OF SACUBITRIL/VALSARTAN IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH HIGH CHARLSON COMORBIDITY INDEX
沙庫巴曲/纈沙坦在Charlson合併症指數較高的AMI患者中的真實世界評估
Hongya liu, Yukun Zhang, Sutao Hu, 顧天舒，Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 1235 – Heart Failure and Cardiomyopathies 11
[Board 143] DIFFERENCES IN THE EFFICACY OF β-BLOCKER THERAPY AFTER ACUTE MYOCARDIAL INFARCTION IN DIFFERENT TYPES OF HEART FAILURE
不同型別的心衰患者發生AMI後進行β受體阻滯劑治療的療效差異
顧天舒，Yukun Zhang, Sutao Hu, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, 王林，Jinhua Zhao, 劉彤，陳康寅，天津醫科大學第二醫院
Presentation | 1231 – Ischemic Heart Diseases 11
[Board 78] ASSOCIATION OF PSORIASIS AND ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASES: MEDIATING ROLE OF INFLAMMATION AND MICROVASCULAR DYSFUNCTION
炎症和微血管功能障礙介導作用試驗：探究銀屑病與冠脈疾病患者心血管不良事件的相關性
Sizhuang Huang, Lingzhi Zhong, Mengyue Yu, Hao Zhang, Yanwen Fang, Lin Sun，中國醫學科學院阜外醫院，北京大學人民醫院
Presentation | 1256 – Complex Clinical Cases: Cardiac Arrhythmias 12
[Board 227] KILL TWO BIRDS WITH ONE STONE-BIVENTRICULAR PACING IMPROVES CARDIAC FUNCTION BY LEADING TO GLOBAL SYNCHRONIZATION AND ELIMINATION OF THE SUPRAVENTRICULAR TACHYCARDIA
一石一鳥：雙心室起搏透過實現全域性同步和消除室上性心動過速來改善心臟功能
褚松筠，盛琴慧，周菁，北京大學第一醫院
Presentation | 1007 – Emerging Evidence in Hypertension Management For Cardiovascular Disease Prevent
BLOOD PRESSURE AND MORTALITY IN THE ADULTS AGED 80 OR OLDER: A COMPREHENSIVE ANALYSIS OF NATIONAL SURVEYS IN THE UNITED STATES
美國全國調查的綜合分析：≥80歲成年人的血壓與死亡率的關係
楊歡歡, Chenxi Huang, Mitsuaki Sawano, Jeph Herrin, Zhihui Li, Erica Sarah Spatz, Harlan M. Krumholz, Yuan Lu，耶魯大學紐黑文醫院，清華大學
Presentation | 1286 – Valvular Diseases 13
[Board 128] ARTIFICIAL-INTELLIGENCE BASED PREDICTION MODEL FOR THIRTY-DAY MORTALITY OF TAVR PATIENTS IN CHINA: A NATIONAL STUDY FROM NTCVR COHORT
一項來自NTCVR佇列的全國性研究：基於人工智慧的中國TAVR患者30天死亡率預測模型
Qifeng Zhu，劉先寶，王建安，浙江大學醫學院附屬第二醫院
Presentation | 1006 – Lipids and Lipoproteins: New Insights on Cardiovascular Cornerstones
EXCESS APOLIPOPROTEIN B AND FUTURE CARDIOVASCULAR RISK IN PATIENTS WITH PREDIABETES
糖尿病前期患者載脂蛋白B超負荷與未來心血管風險之間的關係
Xiaozhao Lu, Huangtao Ruan, Yibo He, Jin Liu, 劉勇，譚寧，陳紀言，廣東省人民醫院
Presentation | 1009 – Durable Left Ventreicular Assist Devices: Outcomes and Social Determinants of H
AORTIC ROOT STASIS AS MEASURED BY DELTA HOUNSFIELD UNIT OF AORTIC CUSPS ON CARDIAC CT: A NOVEL PREDICTOR OF STROKE AND AORTIC ROOT THROMBOSIS IN PT WITH HM 3 LVAD IMPLANTATION
透過心臟CT主動脈瓣尖的δ亨氏單位（HU）變化測量主動脈根部血流停滯：在植入HM3 LVAD的患者中作為卒中及主動脈根部血栓形成的一種新型預測指標
Min-Fang Chao, Mahwash Kassi, Katelyn E. Ingram, Aneesh Dhore, Catherine Teng, Vivek Amit Modi, Abhiraj Sinha, Su Min Chang，高雄醫學大學附設中和紀念醫院
Presentation | 1239 – Complex Clinical Cases: Multimodal Imaging 11
[Board 190] PIERCED BY MISFORTUNE: UNRAVELING THE MYSTERY OF A PATIENT WITH RECURRENT INFECTIVE ENDOCARDITIS
不幸的刺穿：揭開一名複發性感染性心內膜炎患者的神秘面紗
Tin Wah Christopher Lau，香港東區尤德夫人那打素醫院
Presentation | 1246 – Multimodal Imaging 12
[Board 89] INTERVENTIONAL TRANSESOPHAGEAL ECHOCARDIOGRAM: FEATURES AND RISKS IN SIMPLE VERSUS COMPLEX STRUCTURAL HEART INTERVENTIONS
介入性經食管超聲心動圖：簡單與複雜結構性心臟病介入治療中的特徵和風險
Chak Yu So, Jianqiang Xu, Hei Tung Vyanne Chan, Angel Lai, Geri Wong, Kevin Kam, Alex Pui-Wai Lee, Bryan P. Yan，香港中文大學
Presentation | 1267 – Heart Failure and Cardiomyopathies 13
[Board 182] A 1-YEAR EVALUATION OF A MULTIDISCIPLINARY HEART FAILURE PROGRAM AT A TERTIARY REFERRAL CENTER IN HONG KONG
在香港一家三級轉診中心進行的多學科心力衰竭專案的1年評估結果
Esmond Yan Hang Fong，香港伊利沙伯醫院
醫脈通是專業的線上醫生平臺，“感知世界醫學脈搏，助力中國臨床決策”是平臺的使命。醫脈通旗下擁有「臨床指南」「用藥參考」「醫學文獻王」「醫知源」「e研通」「e脈播」等系列產品，全面滿足醫學工作者臨床決策、獲取新知及提升科研效率等方面的需求。

相關文章